Pacer Advisors’s Biohaven BHVN Stock Holding History

Pacer Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,113	Closed	-$38.6K	–	2580
2024 Q2	$38.6K	Buy	1,113 +376	+51%	+$14.9K	﹤0.01%	3279
2024 Q1	$40.3K	Buy	+737	New	+$36.5K	﹤0.01%	3257

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Pacer Advisors's BHVN Position: Q3 2024 in Review

Pacer Advisors sold out of Biohaven (BHVN) in Q3 2024, closing a stake of 1,113 shares — an estimated $38.6K sold.

Pacer Advisors first reported a position in BHVN in Q1 2024 and held it in 2 quarters. The position peaked at $40.3K in Q1 2024. 254 funds tracked by Wall St. Rank hold BHVN as of Q3 2024.

Pacer Advisors reported no remaining Biohaven position as of Q3 2024 after selling out during the quarter.
Pacer Advisors sold 1,113 Biohaven shares in Q3 2024, an estimated $38.6K.
Pacer Advisors first reported a position in Biohaven in Q1 2024 and held it in 2 quarters.
Pacer Advisors's Biohaven position peaked at $40.3K in Q1 2024.
254 funds tracked by Wall St. Rank held Biohaven as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.